X

United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release

Newsdesk: